153 related articles for article (PubMed ID: 38108984)
1. Neuropsychological functioning during chemotherapy with temozolomide in high-grade glioma patients: a retrospective single centre study.
Abete-Fornara G; Bintintan Socaciu P; Fanizzi C; Fiore G; Locatelli M; Caroli M
J Neurooncol; 2023 Dec; 165(3):561-568. PubMed ID: 38108984
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide in paediatric high-grade glioma: a key for combination therapy?
Verschuur AC; Grill J; Lelouch-Tubiana A; Couanet D; Kalifa C; Vassal G
Br J Cancer; 2004 Aug; 91(3):425-9. PubMed ID: 15266331
[TBL] [Abstract][Full Text] [Related]
4. "One week on-one week off": efficacy and side effects of dose-intensified temozolomide chemotherapy: experiences of a single center.
Galldiks N; Berhorn T; Blau T; Dunkl V; Fink GR; Schroeter M
J Neurooncol; 2013 Apr; 112(2):209-15. PubMed ID: 23299464
[TBL] [Abstract][Full Text] [Related]
5. Upfront Therapy of Aggressive/High-Risk Low-Grade Glioma: Single-Institution Outcome Analysis of Temozolomide-Based Radio-Chemotherapy and Adjuvant Chemotherapy.
Anand S; Chatterjee A; Gupta T; Panda P; Moiyadi A; Epari S; Patil V; Krishnatry R; Goda JS; Jalali R
World Neurosurg; 2021 Oct; 154():e176-e184. PubMed ID: 34245877
[TBL] [Abstract][Full Text] [Related]
6. Rechallenge with temozolomide in patients with recurrent gliomas.
Wick A; Pascher C; Wick W; Jauch T; Weller M; Bogdahn U; Hau P
J Neurol; 2009 May; 256(5):734-41. PubMed ID: 19240962
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
[No Abstract] [Full Text] [Related]
8. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
[TBL] [Abstract][Full Text] [Related]
9. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
10. Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings.
Hilverda K; Bosma I; Heimans JJ; Postma TJ; Peter Vandertop W; Slotman BJ; Buter J; Reijneveld JC; Klein M
J Neurooncol; 2010 Mar; 97(1):89-94. PubMed ID: 19718545
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of preirradiation temozolomide in cases of high-grade gliomas: Our experience and review of literature.
Arora S; Rathi AK; Singh K; Ansari FA
J Cancer Res Ther; 2023; 19(2):221-227. PubMed ID: 37006062
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology).
Villani V; Anghileri E; Prosperini L; Lombardi G; Rudà R; Gaviani P; Rizzato S; Lanzetta G; Fabi A; Scaringi C; Pronello E; Simonetti G; Targato G; Pace A
J Neurol; 2021 Aug; 268(8):2866-2875. PubMed ID: 33609154
[TBL] [Abstract][Full Text] [Related]
13. Prolonged administration of temozolomide in adult patients with anaplastic glioma.
Freyschlag CF; Smolczyk DR; Janzen E; Schmieder K; Thomé C; Lohr F; Wenz F; Weiss C; Tuettenberg J; Seiz M
Anticancer Res; 2011 Nov; 31(11):3873-7. PubMed ID: 22110212
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
15. Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review.
Ashby LS; Smith KA; Stea B
World J Surg Oncol; 2016 Aug; 14(1):225. PubMed ID: 27557526
[TBL] [Abstract][Full Text] [Related]
16. Temozolomide after radiotherapy in recurrent "low grade" diffuse brainstem glioma in adults.
Reyes-Botero G; Laigle-Donadey F; Mokhtari K; Martin-Duverneuil N; Delattre JY
J Neurooncol; 2014 Dec; 120(3):581-6. PubMed ID: 25139026
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study.
Perry JR; Bélanger K; Mason WP; Fulton D; Kavan P; Easaw J; Shields C; Kirby S; Macdonald DR; Eisenstat DD; Thiessen B; Forsyth P; Pouliot JF
J Clin Oncol; 2010 Apr; 28(12):2051-7. PubMed ID: 20308655
[TBL] [Abstract][Full Text] [Related]
18. Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule: the "rescue" approach.
Perry JR; Rizek P; Cashman R; Morrison M; Morrison T
Cancer; 2008 Oct; 113(8):2152-7. PubMed ID: 18756530
[TBL] [Abstract][Full Text] [Related]
19. Rechallenge with temozolomide in recurrent glioma.
Gaviani P; Silvani A; Lamperti E; Botturi A; Fariselli L; Simonetti G; Ferrari D; Salmaggi A
Neurol Sci; 2011 Nov; 32 Suppl 2():S247-9. PubMed ID: 21987286
[TBL] [Abstract][Full Text] [Related]
20. Low peripheral lymphocyte count before focal radiotherapy plus concomitant temozolomide predicts severe lymphopenia during malignant glioma treatment.
Ishikawa E; Yamamoto T; Sakamoto N; Nakai K; Akutsu H; Tsuboi K; Takano S; Matsumura A
Neurol Med Chir (Tokyo); 2010; 50(8):638-44. PubMed ID: 20805645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
